Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Probable cause of EGS identified
Equines suffering from mild EGS can sometimes be treated with nursing and supportive care.
Discovery of neurotoxin could lead to new treatments.

Researchers from across several organisations have collaborated to identify a neurotoxin as the probable cause of equine grass sickness (EGS).

It is hoped that the discovery of this neurotoxin could lead to better diagnostics and novel treatments which would improve outcomes for the disease.

EGS is recognised by a rapid degeneration of a horse’s nerves, which leads to the paralysis of the gastrointestinal tract, an inability to swallow, abdominal pain and more.

There is no effective treatment for the most severe cases of the disease, and so many horses are euthanised on humane grounds. Some mild forms can be treated with nursing and supportive care.

The researchers believe that a neurotoxic enzyme, called phospholipase A2, may be responsible for EGS. The neurotoxin has similar actions to snake venom toxins, however it is produced by pasture microbes.

Electron microscopy was used to identify major abnormalities in affected horses, which researchers say represent a toxin-specific signature for the neurotoxin. These abnormalities were identified in horses’ neuromuscular junctions – microscopic communication sites between nerves and muscles which are crucial for normal muscle function.

Neurotoxic phospholipase A2 toxins are also present in the venom of poisonous snakes and, consequently, similarities have been drawn between signs of EGS and snake envenomation. Although there is currently no suggestion that snakes are causing EGS, it is hoped that the same drugs used to treat nerve regeneration in people paralysed by snake bites could be used to treat EGS.

The neurotoxin has now also been linked to animal dysautonomias, which contradicts previous theories which suggested EGS was a form of botulism.

Now that the toxin has been identified, there is work underway to confirm its source.

Currently, it is considered to be the result of a bacterium or fungus that grows in horses’ pastures. It normally grows in cold and dry weather, which usually precedes an outbreak of the disease.

The discovery was the result of work from several organisations: the Dick Vet Equine Hospital at the University of Edinburgh, Newcastle University, Istituto Zooprofilattico Sperimentale delle Venezie and the University of Padova.

Bruce McGorum, of the Royal (Dick) School of Veterinary Studies, said: “Identifying a probable cause of Equine Grass Sickness represents a significant breakthrough. We hope that this discovery will lead to novel treatments and improved diagnostics for this devastating condition.

“We are very grateful for the generous support we have received from horse owners, veterinary surgeons, scientists, charities and funding bodies.”

The full study can be read here.

Image © Equine Veterinary Journal

Become a member or log in to add this story to your CPD history

Antibiotic Amnesty survey opens

News Story 1
 The Responsible Use of Medicines Alliance - Companion Animal and Equine (RUMA - CA&E) has launched a survey which seeks to measure the success of this year's Antibiotic Amnesty campaign.

Its results will help the group to calculate how many unused or out-of-date antibiotics were returned as part of the campaign throughout November. Practices are also asked how they engaged with clients to raise awareness of the issue.

Participating practices can enter a prize draw to win up to 100 in vouchers for taking part. Further prizes from BSAVA and Webinar Vet will be available for practices with the best input.

The survey takes a few minutes to complete and will be running throughout December. It can be accessed via this link

Click here for more...
News Shorts
Bluetongue cases lead to restricted zone extension

Following the detection of new cases of bluetongue virus serotype 3 (BTV-3), the restricted zone has been extended to include additional parts of Hampshire, Wiltshire, Oxfordshire and North Yorkshire, as well as Bournemouth, Christchurch, Poole and part of Dorset.

The zone now covers 28 counties and unitary authorities in England. As of 16 December, 185 cases of BTV-3 have been confirmed in England and Wales during the current vector period.

Bluetongue is a notifiable disease. Suspected cases must be reported on 03000 200 301 in England or 03003 038 268 in Wales. In Scotland, suspected cases should be reported to the local field services office. Suspected cases in Northern Ireland should be reported to the DAERA Helpline on 0300 200 7840 or by contacting the local DAERA Direct Veterinary Office.

A map of the area where movement restrictions apply can be found here.